This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Bioage Labs, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Matthias Geyer: Innovator in NLRP3 Inflammasome Inhibition
Introduction
Matthias Geyer is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of biomedical research, particularly in the area of inflammasome inhibition. His work is crucial for developing therapies that target inflammatory diseases.
Latest Patents
Matthias Geyer holds a patent for "Inhibitors of NLRP3 Inflammasome." This innovation is aimed at addressing various health conditions linked to inflammation, showcasing his commitment to advancing medical science. He has 1 patent to his name.
Career Highlights
Geyer is currently associated with BioAge Labs, Inc., a company focused on leveraging the biology of aging to develop therapeutics. His role at BioAge Labs highlights his dedication to innovative research and development in the biotechnology sector.
Collaborations
Throughout his career, Matthias has collaborated with esteemed colleagues such as Paul Humphries and Yan Wang. These partnerships have further enriched his research and contributed to the advancement of their shared goals in scientific innovation.
Conclusion
Matthias Geyer stands out as a key figure in the field of inflammasome research, with his patent and work at BioAge Labs, Inc. reflecting his impactful contributions to medical science. His ongoing efforts continue to inspire advancements in therapeutic solutions for inflammatory diseases.